633 related items for PubMed ID: 11379808
1. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
2. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
[Abstract] [Full Text] [Related]
3. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
[Abstract] [Full Text] [Related]
4. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD, Walters EG.
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[Abstract] [Full Text] [Related]
5. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ, Stampone P, O'Connor BJ.
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[Abstract] [Full Text] [Related]
6. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[Abstract] [Full Text] [Related]
7. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF, Buist AS.
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[Abstract] [Full Text] [Related]
8. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.
Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
[Abstract] [Full Text] [Related]
9. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[Abstract] [Full Text] [Related]
10. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
[Abstract] [Full Text] [Related]
11. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[Abstract] [Full Text] [Related]
12. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
13. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
14. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
Bousquet J, Cantini L.
Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
[Abstract] [Full Text] [Related]
15. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A, Richter A, Oster H, Criée CP.
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[Abstract] [Full Text] [Related]
16. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
Br J Clin Pract; 1997 Nov; 51(1):11-5. PubMed ID: 9158265
[Abstract] [Full Text] [Related]
17. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
Ederle K, Multicentre Study Group.
Eur Rev Med Pharmacol Sci; 2003 Nov; 7(2):45-55. PubMed ID: 12911119
[Abstract] [Full Text] [Related]
18. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D.
Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
[Abstract] [Full Text] [Related]
19. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
J Aerosol Med; 2002 Jun; 15(4):407-14. PubMed ID: 12581507
[Abstract] [Full Text] [Related]
20. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
Wolthers OD.
Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
